Search:
 
BIOTHERAPEUTICS

 

USV has been successful in developing therapeutic proteins and peptides by recombinant* and chemical synthesis processes. These include hGH, Enterokinase, hG-CSF, Teriparatide and Nesiritide which have been developed using recombinant DNA (rDNA) technology and Eptifibatide and Bivalirudin, by chemical synthesis.

Product Status
  Eptifibatide   Commercialized
  Enterokinase   Commercialized
  Bivalirudin   Ready to be Commercialized
  rhGH   Clinicals
  Nesiritide   Clinicals
  Teriparatide   Pre-clinicals
  rhG-CSF   Pre-clinicals
  PDGF-BB   Pre-clinicals
  PEG-IFN   Scale-up
* We are open to third party product development using our expression platforms. Contact us for details.

Disclaimer: Products under patents are offered for sale only in those countries where patents have expired.
 
 
Current Product Range
Eptifibatide
Enterokinase
Contact Us